Annovis Bio, Inc. · NYSE:ANVS
Highbridge Capital Management LLC reported a 6.10% stake in Annovis Bio, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Highbridge Capital Management LLC reported a 6.10% stake in Annovis Bio, Inc., 2,775,578 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 6.10%
- Shares
- 2,775,578
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Highbridge Capital Management, LLC | 6.10% | 2,775,578 |
Source
Related
- Annovis Bio, Inc.
- Highbridge Capital Management LLC
- Annovis Bio, Inc. shareholders
- Schedule 13G/A · Empery Asset Management, LP · Oct 15, 2026
- Schedule 13G · Empery Asset Management, LP · Jul 29, 2026
- Form 4 · Hoffman Michael B · May 21, 2026
- Form 4 · Hoffman Michael B · Apr 3, 2026
- Schedule 13G/A · CVI Investments, Inc. · May 12, 2025